Last updated at 11 Jul 2024 01:38 AM
Director
DIN: 09185973
Smita Jhanwar is currently associated with 3 companies in various capacities such as Director and Individual Promoter. They serve as a Director at MEDICORUM PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09185973.Smita Jhanwar is currently involved in 2 different roles. Their most recent position is with RAMADEUS CAPSULES PRIVATE LIMITED as a Director. The first company Smita Jhanwar was appointed to as a director was MEDICORUM PHARMACEUTICALS PRIVATE LIMITED. Smita Jhanwar is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Smita Jhanwar is currently associated with 3 companies in various capacities such as Director and Individual Promoter. They serve as a Director at MEDICORUM PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09185973.Smita Jhanwar is currently involved in 2 different roles. Their most recent position is with RAMADEUS CAPSULES PRIVATE LIMITED as a Director. The first company Smita Jhanwar was appointed to as a director was MEDICORUM PHARMACEUTICALS PRIVATE LIMITED. Smita Jhanwar is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Female
India
Gain instant access to verified contact details.
Current Companies (3)
Current LLPs (0)
Past Companies (0)
11 Months 6 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| MEDICORUM PHARMACEUTICALS PRIVATE LIMITED | Director | 27-May-2021 |
| MEDICORUM PHARMACEUTICALS PRIVATE LIMITED | Individual Promoter | 27-May-2021 |
| INDICAPS HEALTHCARE PRIVATE LIMITED | Director | 09-Jun-2021 |
| RAMADEUS CAPSULES PRIVATE LIMITED | Director | 22-Feb-2022 |